» Articles » PMID: 36699052

Targeting LncRNAs of Colorectal Cancers with Natural Products

Overview
Journal Front Pharmacol
Date 2023 Jan 26
PMID 36699052
Authors
Affiliations
Soon will be listed here.
Abstract

Non-coding RNA (ncRNA) is one of the functional classes of RNA that has a regulatory role in various cellular processes, such as modulation of disease onset, progression, and prognosis. ncRNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), have been actively studied in recent years. The change in ncRNA levels is being actively studied in numerous human diseases, especially auto-immune disorders and cancers; however, targeting and regulating ncRNA with natural products to cure cancer has not been fully established. Recently many groups reported the relationship between ncRNA and natural products showing promising effects to serve as additional therapeutic approaches to cure cancers. This mini-review summarizes the aspects of lncRNAs related to cancer biology focusing on colorectal cancers that natural products can target.

Citing Articles

Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer.

Doghish A, Mageed S, Mohammed O, Abdel-Reheim M, Zaki M, Mohamed A Funct Integr Genomics. 2025; 25(1):42.

PMID: 39982533 DOI: 10.1007/s10142-025-01547-8.


Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance.

Elimam H, Eldeib M, Kizilaslan E, Alhamshry N, Ashour A, Elfar N Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1243-1263.

PMID: 39287672 DOI: 10.1007/s00210-024-03425-9.


Diagnostic and prognostic potential of exosome non-coding RNAs in bladder cancer: a systematic review and meta-analysis.

Chen Y, Shi K, Fu X, Guo H, Gao T, Yu H Front Oncol. 2024; 14:1336375.

PMID: 38500660 PMC: 10944871. DOI: 10.3389/fonc.2024.1336375.


A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinoma.

Samadi P, Shahnazari M, Shekari A, Maghool F, Jalali A Cancer Cell Int. 2023; 23(1):307.

PMID: 38042769 PMC: 10693120. DOI: 10.1186/s12935-023-03163-7.


Strategic and Innovative Roles of lncRNAs Regulated by Naturally-derived Small Molecules in Cancer Therapy.

Alkan A, Ensoy M, Cansaran-Duman D Curr Med Chem. 2023; 31(40):6672-6691.

PMID: 37921177 DOI: 10.2174/0109298673264372230919102758.

References
1.
Wu G, Niu M, Qin J, Wang Y, Tian J . Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells. Gene. 2019; 709:48-55. DOI: 10.1016/j.gene.2019.04.005. View

2.
Che Hassan N, Taher M, Susanti D . Phytochemical constituents and pharmacological properties of Garcinia xanthochymus- a review. Biomed Pharmacother. 2018; 106:1378-1389. DOI: 10.1016/j.biopha.2018.07.087. View

3.
Boots A, Haenen G, Bast A . Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585(2-3):325-37. DOI: 10.1016/j.ejphar.2008.03.008. View

4.
Ye L, Zhu D, Qiu J, Xu J, Wei Y . Involvement of long non-coding RNA in colorectal cancer: From benchtop to bedside (Review). Oncol Lett. 2015; 9(3):1039-1045. PMC: 4315074. DOI: 10.3892/ol.2015.2846. View

5.
Fabian A, Bor R, Szepes Z . The use of ultrasound in colonic and perianal diseases. Curr Opin Gastroenterol. 2022; 39(1):50-56. PMC: 9799033. DOI: 10.1097/MOG.0000000000000891. View